Correction to: Efficacy, Safety, and Exposure of Apixaban in Patients with High Body Weight or Obesity and Venous Thromboembolism: Insights from AMPLIFY. | Adv Ther;38(8): 4596-4597, 2021 Aug. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Correction to: Efficacy, Safety, and Exposure of Apixaban in Patients with High Body Weight or Obesity and Venous Thromboembolism: Insights from AMPLIFY.

Cohen, Alexander T; Pan, Sharon; Byon, Wonkyung; Ilyas, Bushra S; Taylor, Thomas; Lee, Theodore C.

Affiliation

Cohen AT; Guy's and St Thomas' Hospitals, Westminster Bridge Road, London, UK. alexander.cohen@kcl.ac.uk.
Pan S; Pfizer, New York, USA.
Byon W; Pfizer, New York, USA.
Ilyas BS; Pfizer, New York, USA.
Taylor T; Guy's and St Thomas' Hospitals, Westminster Bridge Road, London, UK.
Lee TC; Pfizer, New York, USA.

Adv Ther ; 38(8): 4596-4597, 2021 Aug.

Article in En | MEDLINE | ID: mdl-34240312

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Adv Ther Journal subject: TERAPEUTICA Year: 2021 Document type: Article Affiliation country:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Adv Ther Journal subject: TERAPEUTICA Year: 2021 Document type: Article Affiliation country: